Category Archives: Global

And What Exactly is a Stakeholder?

By Julian Upton | Published: August 19, 2010
Pharma’s uncritical use of the word ‘stakeholder’ has increased to the point where it can refer to almost anyone connected to the industry. But this can have serious consequences, warns Reflector. Like it or not (and frankly, I don’t), stakeholders are here to stay in European pharmaceutical affairs. Don’t get me wrong. I’ve no objection to [...]
Also posted in Europe, Guest Blog, Regulatory | Tagged , , , , , , , , | 1 Comment

Patients Want to Talk. Do You?

By Julian Upton | Published: August 18, 2010
Why are companies rushing to the web when traditional engagement with patient groups remains so under-exploited, asks Jacky Law. It used to be so easy. Patients listened to doctors, doctors listened to pharma and everyone was happy. There was even a time when payers listened to pharma, reimbursing their prices with very few questions asked. Now [...]
Also posted in E-Media, Europe, FDA, Guest Blog, Legal | Tagged , , , , , | 1 Comment

HTA Concerns From European Drug Agency

By Julian Upton | Published: June 18, 2010
The EMA’s Thomas Lönngren has gone public with his disquiet over organizations such as NICE. But pharma still needs more allies in fighting what it sees as the failings of the health technology assessment bodies, says Pharm Exec Europe’s Brussels correspondent, Reflector. Europe’s pharmaceutical firms were never very keen on Britain’s influential National Institute for Health [...]
Also posted in Europe, Guest Blog, Regulatory, Safety, Strategy | Tagged , , , , | Leave a comment

WHO Threatens Industry Shut-out on Counterfeit Regulation

By William Looney | Published: May 26, 2010
Big Pharma believes that a global generics franchise might give it a softer landing off the patent cliff, but governments that sponsor and regulate the industry are still acting a bit slow on the uptake. The reason? Anti-IP activists are again poisoning the well on global access to medicines, engaging the bigger emerging market governments [...]
Posted in Global | Tagged , , , , , , | Leave a comment

Judgment Day for Pfizer Factories

By Oriana Schwindt | Published: May 19, 2010
For once, pharma sales reps and R&D guys can breathe a sigh of relief. The latest round of industry layoffs comes from Pfizer, but this time it will affect the manufacturing force, which will be downsized by 6,000 employees by 2015. In 2006, the company announced plans to save $4 billion to $5 billion, and after [...]
Also posted in Europe, Manufacturing, News, Strategy | Tagged , , , , , , | Leave a comment